Professor Chris Packard
Glasgow (United Kingdom of Great Britain & Northern Ireland)
PCSK9 inhibitors: the evidence-based story
Event: ESC Congress 2017
Topic: Atherosclerosis
Session type: Satellite Symposium - Experts on the Spot
ESC 365 is supported by
